fda on semaglutide A big win for Wegovy: Weight loss drug first in history to gain approval for reducing heart risks FDA Declares Shortage of Novo

My infographic gives a quick overview, but I wanted to dive a bit deeper into what I've learned, particularly about GLP-1, since it's such a hot topic

It is essential to recognize that correlation does not equal causation

If there were sufficient studies, then we used funnel plots to assess the possibility of reporting biases or small study biases, or both

Its vulnerable

Anti-proliferative activity of glucagon-like peptide-1 receptor agonist on obesity-associated breast cancer: the impact on modulating adipokines' Expression in adipocytes and cancer cells

These may include oily or fatty stools, gas, and more frequent bowel movements, especially with high-fat meals.